Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
2.910
+0.030 (1.04%)
Jan 21, 2025, 4:00 PM EST - Market closed
Sunshine Biopharma Employees
Sunshine Biopharma had 44 employees as of December 31, 2023. The number of employees decreased by 2 or -4.35% compared to the previous year.
Employees
44
Change (1Y)
-2
Growth (1Y)
-4.35%
Revenue / Employee
$749,079
Profits / Employee
-$96,044
Market Cap
5.82M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
SBFM News
- 15 hours ago - Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT - Accesswire
- 6 days ago - Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer - Accesswire
- 6 weeks ago - Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus - Accesswire
- 6 weeks ago - Sunshine Biopharma Launches a New Generic Prescription Drug - Accesswire
- 7 weeks ago - Sunshine Biopharma Announces Breakthrough Research Results on the Company's K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma - Accesswire
- 2 months ago - Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54% - Accesswire
- 4 months ago - Sunshine Biopharma Launches Two New Generic Prescription Drugs - Accesswire
- 4 months ago - Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry - Accesswire